Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/1021   
Active ingredient: 1-[(2-Chloro-4-methoxyphenoxy)methyl]-4-[(2,6-dichlorophenoxy)methyl]benzene
Indication: Prevention of poliomyelitis in patients with immunodeficiencies deemed at risk
Sponsor: ViroDefense Ltd
The Catalyst, Suite G17, University of York, Baird Lane, York 010 5GA, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2012 Centralised Orphan - Designation EMA/OD/025/12 (2012)5142 of 17/07/2012
18/01/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/025/12/T/01 (2013)280 of 16/01/2013